Ignite Creation Date:
2025-12-25 @ 3:39 AM
Ignite Modification Date:
2026-02-22 @ 7:23 PM
Study NCT ID:
NCT06892002
Status:
COMPLETED
Last Update Posted:
2025-08-15
First Post:
2025-01-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Description of Patients With Type 1 Diabetes Treated With Teplizumab
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-02-11
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-08-05
Completion Date Type:
ACTUAL
First Submit Date:
2025-01-24
First Submit QC Date:
None
Study First Post Date:
2025-03-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-14
Last Update Post Date:
2025-08-15
Last Update Post Date Type:
ACTUAL